文献速递心脑血管急症重症综合管理与镇静镇痛

SARS-CoV-2 定植冠状动脉血栓并损害无症状 SARS-CoV-2 阳性急性心肌梗死患者的心脏微循环床

SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.
PubMed 文献 · Crit Care · 2021-06-24
一句话结论无症状 SARS-CoV-2 阳性 STEMI 患者血栓病毒载量更高、血栓更大、心肌灌注更差,住院 MACE 生存更低,作者认为应将 ASAP 状态视为可能恶化 STEMI 结局的危险因素。

该观察性研究纳入 46 例无症状 SARS-CoV-2 阳性(ASAP)和 130 例 SARS-CoV-2 阴性(SANE)确诊 STEMI 并接受直接 PCI 及血栓抽吸的患者,主要终点为血栓大小和血栓病毒载量对 PPCI 后心肌灌注(MBG)的影响。ASAP 组较 SANE 组血栓 5 级比例和血栓尺寸更高(p<0.05),MBG 和左心室功能更低(p<0.001),39 例(84.9%)ASAP 患者血栓标本 SARS-CoV-2 阳性;PPCI 后 MBG 2-3 者 ASAP 组仅 26.1% vs SANE 组 97.7%(p<0.001)。ASAP 组死亡和非致死性 AMI 更高(p<0.05),住院 MACE 生存显著更低(p<0.001)。作者认为 ASAP 状态可能是恶化 STEMI 结局的危险因素。

要点

  • ASAP 组 STEMI 患者 PPCI 后 MBG 2-3 仅 26.1%,显著低于 SANE 组的 97.7%(p<0.001)。
  • ASAP 组 39 例(84.9%)血栓标本 SARS-CoV-2 阳性,血栓病毒载量是血栓大小的独立决定因素(p<0.005)。
  • ASAP 组较 SANE 组血栓 5 级比例和血栓尺寸更高(p<0.05),GP IIb/IIIa 抑制剂和肝素使用更多(p<0.05)。
  • ASAP 组死亡和非致死性 AMI 高于 SANE 组(p<0.05),住院 MACE 生存显著更低(p<0.001)。
  • ASAP 组女性较男性血栓病毒载量更高(15.53 ± 4.5 vs 30.25 ± 5.51 CT;p<0.001),血栓尺寸更大(4.62 ± 0.44 vs 4.00 ± 1.28 mm2;p<0.001)。

适用人群与场景

  • 确诊 STEMI 并接受直接经皮冠状动脉介入治疗(PPCI)和血栓抽吸的患者,包括无症状 SARS-CoV-2 阳性(ASAP)46 例和 SARS-CoV-2 阴性(SANE)130 例。

研究设计与关键结果

  • 观察性研究纳入 46 例 ASAP 和 130 例 SANE 确诊 STEMI 并接受 PPCI 和血栓抽吸的患者,主要终点为血栓尺寸和血栓病毒载量对 PPCI 后 MBG 的影响,次要终点为住院期间 MACEs(心血管死亡、非致死性急性 AMI 和心力衰竭的复合终点)。
  • ASAP 组 vs SANE 组:GP IIb/IIIa 抑制剂和肝素使用更多(p<0.05),血栓 5 级比例和血栓尺寸更高(p<0.05)。
  • ASAP 组 vs SANE 组:MBG 和左心室功能更低(p<0.001),39 例(84.9%)ASAP 患者血栓标本 SARS-CoV-2 阳性。
  • PPCI 后 MBG 2-3 者 ASAP 组仅 26.1% vs SANE 组 97.7%(p<0.001)。
  • ASAP 组 vs SANE 组:死亡和非致死性 AMI 更高(p<0.05)。
  • ASAP STEMI 患者中,血栓病毒载量是血栓尺寸的显著决定因素,独立于危险因素(p<0.005)。
  • 多因素 logistic 回归分析显示,血栓 SARS-CoV-2 感染和血栓尺寸是 STEMI 患者 MBG 较差的显著预测因素。
  • ASAP 患者中,女性 vs 男性血栓病毒载量更高(15.53 ± 4.5 vs 30.25 ± 5.51 CT;p<0.001),血栓尺寸更大(4.62 ± 0.44 vs 4.00 ± 1.28 mm2;p<0.001)。

证据类型、等级与局限

  • 证据类型:观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,ASAP 状态应重新被视为可能恶化 STEMI 结局的危险因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The viral load of asymptomatic SAR-COV-2 positive (ASAP) persons has been equal to that of symptomatic patients. On the other hand, there are no reports of ST-elevation myocardial infarction (STEMI) outcomes in ASAP patients. Therefore, we evaluated thrombus burden and thrombus viral load and their impact on microvascular bed perfusion in the infarct area (myocardial blush grade, MBG) in ASAP compared to SARS-COV-2 negative (SANE) STEMI patients.

METHODS: This was an observational study of 46 ASAP, and 130 SANE patients admitted with confirmed STEMI treated with primary percutaneous coronary intervention and thrombus aspiration. The primary endpoints were thrombus dimension + thrombus viral load effects on MBG after PPCI. The secondary endpoints during hospitalization were major adverse cardiovascular events (MACEs). MACEs are defined as a composite of cardiovascular death, nonfatal acute AMI, and heart failure during hospitalization.

RESULTS: In the study population, ASAP vs. SANE showed a significant greater use of GP IIb/IIIa inhibitors and of heparin (p < 0.05), and a higher thrombus grade 5 and thrombus dimensions (p < 0.05). Interestingly, ASAP vs. SANE patients had lower MBG and left ventricular function (p < 0.001), and 39 (84.9%) of ASAP patients had thrombus specimens positive for SARS-COV-2. After PPCI, a MBG 2-3 was present in only 26.1% of ASAP vs. 97.7% of SANE STEMI patients (p < 0.001). Notably, death and nonfatal AMI were higher in ASAP vs. SANE patients (p < 0.05). Finally, in ASAP STEMI patients the thrombus viral load was a significant determinant of thrombus dimension independently of risk factors (p < 0.005). Thus, multiple logistic regression analyses evidenced that thrombus SARS-CoV-2 infection and dimension were significant predictors of poorer MBG in STEMI patients. Intriguingly, in ASAP patients the female vs. male had higher thrombus viral load (15.53 ± 4.5 vs. 30.25 ± 5.51 CT; p < 0.001), and thrombus dimension (4.62 ± 0.44 vs 4.00 ± 1.28 mm2; p < 0.001). ASAP vs. SANE patients had a significantly lower in-hospital survival for MACE following PPCI (p < 0.001).

CONCLUSIONS: In ASAP patients presenting with STEMI, there is strong evidence towards higher thrombus viral load, dimension, and poorer MBG. These data support the need to reconsider ASAP status as a risk factor that may worsen STEMI outcomes.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Marfella R, Paolisso P, Sardu C, et al. SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. Crit Care. 2021. PMID: 34167575. doi:10.1186/s13054-021-03643-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。